Viv is a Senior Research Assistant in the Chappell Group.
Viv previously completed her PhD at the Hudson Institute of Medical Research and Monash University in Melbourne, where she investigated how various cell death proteins regulated immunity against bacterial gut infections. After her conferral in 2023, she moved on to research cell death in atherosclerosis and other cardiometabolic diseases at the Victorian Heart Hospital. Now, she is applying her experience in molecular biology to help develop vaccines against respiratory viral diseases for the ViceBio project. Qualifications: Bachelor of Biomedicine (degree with Honours), University of Melbourne Doctor of Philosophy (Microbiology), Monash University.
Key Publications
Yeap HW, Rosli SN, Pung HS, Giogha C, Eng VV, Pearson JS, Hartland EL, Chen KW (2025). A bacterial network of T3SS effectors counteracts host pro-inflammatory responses and cell death to promote infection. EMBO Journal. doi: https://doi.org/10.1038/s44318-025-00412-5
Garnish SE, Martin KR, Kauppi M, Jackson VE, Ambrose R, Eng VV, … Hildebrand JM (2023). A common human MLKL polymorphism confers resistance to negative regulation by phosphorylation. Nature Communications. doi: https://doi.org/10.1038/s41467-023-41724-6
Eng VV, Wemyss MA and Pearson JS (2020). The diverse roles of RIP kinases in host-pathogen interactions. Seminars in Cell & Developmental Biology. doi: https://doi.org/10.1016/j.semcdb.2020.08.005